Patients with high levels of miR‐196a, with a higher risk of progression to EAC, show higher amounts of c‐MYC, TERT, and active p65NFκB subunit compared with BE samples from patients with low miR196a expression levels and a low risk of progression. The gene discussed is TERT; the disease is Barrett esophagus.